ANIK
ANIK
NASDAQ · Biotechnology

Anika Therapeutics Inc

$14.98
+0.48 (+3.31%)
As of Apr 1, 10:08 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +60.1% upside
Low Target $18.55
Average Target $23.98
High Target $27.85
Current Price $14.98
Current
$14.98
Target
$23.98
$18.55 $23.98 avg $27.85
Scenario Analysis
Bear Case
$18.55
23.8%
Low target
Base Case
$23.98
+60.1%
Avg target
Bull Case
$27.85
+85.9%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$15.79
-5.1% from high
52-Week Low
$7.87
+90.3% from low
Target vs 52W High
$23.98
+51.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%